Last Update 07 Sep 26
Fair value Increased 2.38%SDLF: Capital Returns And PRT Venture Will Shape Balanced Risk Outlook
The analyst price target for Standard Life has been raised to £1,075 from £995, with recent research citing mixed views on valuation, capital return options, earnings mix and balance sheet risks as key drivers behind the updated outlook.
Analyst Commentary
Recent research on Standard Life shows a clear split between bullish and bearish analysts, with price targets ranging from £8.85 to £10.75 and rating changes in both directions. For you as an investor, the key debate centers on valuation, capital return potential, earnings quality and balance sheet risk.
Bullish Takeaways
- Bullish analysts point to valuation as supportive, with some upgrades tied to their view that the current price still leaves room relative to their targets around £9.80 to £10.75.
- Several upbeat views reference Standard Life's capital return optionality, which they see as a meaningful part of the equity story if management continues to prioritise shareholder returns.
- Improving earnings mix is flagged as a positive, with bullish analysts highlighting a shift they see as helpful for the quality and resilience of future earnings.
- JPMorgan keeps an Overweight stance with price targets of £9.75 and £10.75 in recent research, which signals confidence in execution against its current strategy.
Bearish Takeaways
- Bearish analysts highlight valuation stretch, noting that Standard Life trades at what they describe as a material premium to European composite peers, which they see as limiting upside.
- One downgrade to Neutral accompanies a higher price target of £10.15, with concerns focused on the risk of negative equity at the first half results, which they view as an important balance sheet flag.
- Some cautious views link rating cuts to the stock's recent performance versus peers, with the view that much of the positive story around capital returns and earnings mix is already reflected in the price.
- Sector Perform style ratings reflect a preference among more cautious analysts to wait for clearer evidence on balance sheet trends and capital usage before taking a stronger stance.
What’s in the News for Standard Life
- CVC Capital Partners and Standard Life have agreed a joint venture to create a new Pension Risk Transfer (PRT) platform focused on large UK corporate pension schemes, with combined initial capital commitments of up to £2 billion to support future transactions. Source, Key Developments
- The PRT venture will be backed by a consortium that includes Prudential Financial Inc and other long-term institutional investors, with CVC committing £400 million of capital to be drawn over multiple years. Source, Key Developments
- CVC will provide Standard Life’s PRT business with access to a broad range of private market investment opportunities across asset-backed lending, structured credit, real estate credit, infrastructure credit, direct lending, opportunistic credit and liquid credit, intended to support long-term liability management objectives. Source, Key Developments
- Standard Life is contributing its existing PRT capabilities, including origination, transaction structuring, regulatory infrastructure and relationships across the UK pensions ecosystem, into the new platform. Source, Key Developments
- Standard Life has held an Analyst and Investor Day, giving the market an opportunity to hear directly from management on its plans and positioning. Source, Key Developments
Valuation Changes for Standard Life
- Fair Value: Standard Life's estimated fair value per share has risen slightly from £8.78 to £8.99.
- Discount Rate: The model discount rate has edged up from 7.80% to 7.84%.
- Revenue Growth: Forecast revenue growth, expressed as a decline, has eased from a fall of 33.58% to a fall of 32.59%.
- Profit Margin: The projected profit margin has moved marginally from 7.77% to 7.76%.
- Future P/E: The implied future P/E multiple has slipped slightly from 16.70x to 16.40x.
Key Takeaways
- Expansion in annuities and workplace pensions boosts revenue opportunities and operating margins, leveraging market growth in retirement solutions.
- Commitment to lower leverage ratio reduces financial risk and interests, potentially improving net margins and investor confidence.
- High leverage and complex hedging strategies may limit Phoenix Group's growth potential, affect investor confidence, and strain compliance with regulatory changes.
Catalysts
About Phoenix Group Holdings- Operates in the long-term savings and retirement business in Europe.
- The upgrade in Phoenix's operating cash generation (OCG) target from £4.4 billion to £5.1 billion by 2026, supported by a disciplined management approach, indicates potential growth in excess cash generation, which could impact future earnings positively.
- The commitment to deleverage and reduce the leverage ratio to 30% by 2026 is expected to lower financial risk and interest expenses, potentially improving net margins and increasing investor confidence.
- A planned increase in IFRS operating profit target from £900 million to £1.1 billion by 2026, driven by a cost-saving strategy and expanding revenue from underlying businesses, supports optimism in improving earnings growth.
- Phoenix Group's strategic growth in annuities and workplace pensions, with significant market opportunities and tailored retirement solutions, could contribute to higher revenues and operating margins over time.
- The focus on digital transformation and improved customer engagement in retail markets aims to enhance customer retention and acquisition, potentially leading to revenue growth and operating efficiencies.
Phoenix Group Holdings Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Standard Life's revenue will decrease by 32.6% annually over the next 3 years.
- Analysts assume that profit margins will increase from -1.6% today to 7.8% in 3 years time.
- Analysts expect earnings to reach £688.1 million (and earnings per share of £0.64) by about September 2029, up from -£472.0 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.4x on those 2029 earnings, up from -20.2x today. This future PE is greater than the current PE for the GB Insurance industry at 16.3x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.84%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The balance sheet pivot to becoming an open book player has lagged the strategic pivot, and Phoenix Group is still highly leveraged, which may affect the ability to grow Own Funds and improve investor perception of financial stability. (Affects leverage ratio and balance sheet strength)
- The hedging strategy, while protecting solvency surplus, leads to known accounting volatility under IFRS 17, including significant mark-to-market losses that are not reflected under Solvency II, potentially affecting investor confidence and reported earnings. (Affects IFRS earnings and shareholders' equity)
- The Solvency II leverage ratio remains resistant to reduction, remaining unchanged despite management actions, with nonrecurring components acting as a drag. This could affect future borrowing capacity and cost of capital. (Affects leverage ratio and cost of debt)
- Despite the strong financial performance, the commitment to deleveraging and hitting a target leverage ratio might limit available cash for reinvestment in growth opportunities, potentially affecting the long-term revenue generation capacity. (Affects capital allocation and future revenue potential)
- Regulatory changes, such as upcoming ESG and environmental disclosure requirements, might require significant investment and resources, which could create additional financial strain and affect nonrecurring costs going forward. (Affects operational costs and compliance expenses)
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of £8.99 for Standard Life based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £10.75, and the most bearish reporting a price target of just £6.65.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £8.9 billion, earnings will come to £688.1 million, and it would be trading on a PE ratio of 16.4x, assuming you use a discount rate of 7.8%.
- Given the current share price of £9.52, the analyst price target of £8.99 is 5.9% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Standard Life?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.